Gliadin.
Gliadin is one of the two proteins in wheat gluten. In products it turns up as hydrolysed wheat protein or as a carrier material, not as an active taken for an effect.
- Category
- Protein
What Gliadin is, and what it does.
- Does it work
- Relevant mainly as something to identify on a label. Anyone eating gluten free needs to know this is a wheat gluten protein under another name.
- How much to take
- There is no supplemental daily amount on record, because gliadin is not taken for an effect of its own. What matters is recognising it in an ingredient list.
- Time to feel it
- Nobody has measured a benefit time course for gliadin, because it is used as a food and formulation protein rather than for a physiological effect.
- The first dose
- Nothing distinct on day one for most people. In anyone who reacts to gluten, wheat protein shows itself within hours, which is why identifying it matters.
- With regular use
- For most people daily intake happens through bread and pasta rather than a supplement. No long term supplemental effect of gliadin itself has been studied.
- How well tolerated
- Gluten is a declared allergen and a protein many people avoid on medical advice. If you avoid gluten, this ingredient belongs on the same list.
- How it feels
- No sensation of its own. In dough it is the protein that gives stretch, which is the only thing most people ever notice about it.
- The overlooked benefit
- It self-assembles into nanoparticles in aqueous ethanol, which food scientists use to encapsulate and protect fragile compounds. That is its main modern formulation role.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- proline and glutamine richness limiting protease digestionNarrative review
- transglutaminase deamidation and HLA-DQ binding of gliadin peptidesNarrative review
- dough extensibility contributed by the prolamin fractionNarrative review
- self-assembly into nanoparticles for encapsulationIn vitro study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Certain lactic acid bacteria degrade proline-rich gliadin fragments during sourdough fermentation and, in laboratory conditions, in gut contents. That is a food-processing observation with limited transfer to a person eating an ordinary meal. It should never be read as making gluten-containing food acceptable for someone who must avoid it.
Human proteases lack the specificity to cut after proline residues, which is why 33-mer gliadin peptides survive digestion. Prolyl endopeptidase preparations cut those bonds in vitro and in the stomach to a degree. Degradation is incomplete and variable with meal composition, so this does not remove exposure.
Bromelain is a broad cysteine protease that cleaves many peptide bonds, so it acts on gliadin as it acts on other dietary protein. It has poor specificity for the proline-rich stretches that matter most. Read it as general proteolysis rather than a targeted approach.
Papain hydrolyses gliadin along with other proteins in the meal and is used industrially to reduce gluten network strength. Like bromelain, it does not preferentially target proline-rich sequences. Its main role with this protein is in food processing rather than in digestion.
Roughly a third of gliadin's amino acid residues are glutamine, and another sixth are proline. This composition is what makes the protein resistant to complete digestion and what gives it its viscoelastic behaviour in dough. The relationship is compositional, not a functional pairing.
Wheat storage proteins and the phytate that accompanies them in grain influence how much zinc is available from a cereal meal. Phytate rather than gliadin itself is the dominant factor. This is a whole-grain matrix effect rather than a property of the isolated protein.
Phytase releases minerals bound to inositol hexaphosphate in wheat, which improves iron and zinc availability from the same flour that carries gliadin. It acts on the phytate, not on the protein. Sourdough fermentation achieves the same thing through endogenous cereal phytase.
Gliadin's amphiphilic character makes it useful for forming nanoparticles and films that carry other actives. Polysaccharides are combined with it to stabilise those particles. This is materials science and has nothing to do with a nutritional effect in a person.
Curcumin dissolves poorly in water, and protein-based nanoparticles including gliadin have been used in laboratory work to disperse it. This is a delivery vehicle observation from food science. It is not a reason to consume gliadin, and anyone avoiding gluten would need to check the carrier.
Nothing specific on file for Gliadin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Gliadin actually does.
This is the alcohol-soluble part of wheat gluten, separate from the other main fraction, and together they form the stretchy network that gives wheat dough its texture.
It's unusually rich in two amino acids that make up about half its structure, which is the direct reason our digestive enzymes can't fully break it down.
An enzyme in the gut modifies certain amino acids in gliadin fragments, making them bind more strongly to specific immune-recognition molecules. This step is central to how the immune system responds to gluten in sensitive people.
Gliadin makes dough stretchy while the other gluten fraction makes it springy, and the balance between the two shapes how bread bakes.
Where Gliadin comes from.
It comes from wheat. Flour is made into dough and washed under water until the starch rinses away, leaving a rubbery protein mass. Alcohol then pulls out one half of that mass, which is gliadin. Rye and barley carry close relatives of it.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Common bread wheat, Triticum aestivum, is the main source. Related prolamins occur in rye as secalin and barley as hordein.
Flour is hydrated into a dough and washed with water to remove starch and soluble components, leaving the wet gluten mass, an old process sometimes called the Martin method.
Wet or dried gluten is extracted with aqueous ethanol, typically 60 to 70 percent, which dissolves the prolamin fraction and leaves glutenin behind. This is the Osborne fractionation.
Acid, enzymatic or heat treatment may be applied to hydrolyse or deamidate the protein, changing its solubility and its behaviour in formulation.
Dried to powder and specified by protein content, solubility and, for food use, gluten content by immunoassay.
Getting Gliadin from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Cocoa supplementation reduced gliadin-associated shifts in intestinal microbial composition in the model animals.Animal study. Girbal-Gonzalez M et al., 2026 (Foods). PMID 41596968 ↗
- Carboxymethyl chitosan limited the loss of gliadin extensibility in frozen rice dough during storage.In vitro study. Dong W et al., 2025 (Food Chemistry: X). PMID 40927626 ↗
- An Auricularia auricula polysaccharide altered the rheological, thermal and structural behaviour of the gluten proteins studied.In vitro study. Li H et al., 2026 (Foods). PMID 41517202 ↗
- Deacetylated konjac glucomannan reduced structural deterioration of gluten and its component proteins across freeze-thaw cycles.In vitro study. Fan J et al., 2026 (Food Chemistry: X). PMID 41696632 ↗
- A review of probiotics as an adjunct to a gluten-free diet, summarising proposed mechanisms including peptide degradation.Narrative review. Ait Said H et al., 2025 (Gastroenterology and Hepatology from Bed to Bench). PMID 41116854 ↗
- A systematic review of dietary factors in pregnancy and later islet autoimmunity, with gluten intake among the exposures examined.Systematic review. Johansen VBI et al., 2023 (Nutrients). PMID 37892409 ↗
These are the studies our verdict leans on, chosen from the 6 we read for Gliadin. The full linked list is below.
The studies, linked.
8 sources behind our Gliadin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialInterpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies RevisitedClinicalTrials.gov ↗2,026 participants, Completed
- Clinical trialHLA-DQ2-gliadin Tetramer for Diagnosis of Celiac DiseaseClinicalTrials.gov ↗Phase 2, 100 participants, Completed
- Clinical trialPhase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in FecesClinicalTrials.gov ↗53 participants, Completed
- Clinical trialA Gliadin Peptide Regulated the INF-α Immune Response in Celiac Small Intestine and in an En-terocyte Cell LineClinicalTrials.gov ↗53 participants, Completed
- Clinical trialConfirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)ClinicalTrials.gov ↗40 participants, Completed
- Clinical trialRandomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-PositiveClinicalTrials.gov ↗26 participants, Completed
- Clinical trialThe Effect of Superoxide Dismutase (SOD) Enzyme on Frailty and Health Related Quality of Life Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled TrialClinicalTrials.gov ↗Phase 4, 150 participants, Unknown
- Clinical trialIn-vivo Study of the Efficacy of Hyperimmune Bovine Colostrum to Block Absorption of Gliadin Peptides in the Human Intestine: a Novel Potential Intervention for Celiac Disease and Non-celiac Gluten SensitivityClinicalTrials.gov ↗Early phase 1, 10 participants, Suspended
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.